EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

An Overview of UBTF Neuroregression Syndrome

Anneliesse A Braden iD, Jianfeng Xiao, Roderick Hori, Chester Brown, Mohammad Moshahid Khan iD

Brain Sciences · 15.02.2024 · 14 (2) · 179

DOI: 10.3390/brainsci14020179 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 15.02.2024. Verfasst von Anneliesse A Braden und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38104, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, a recurrent de novo dominant mutation in UBTF (c.628G>A, p.Glu210Lys; UBTF E210K) was identified as the cause of a neurological disorder which has been named UBTF Neuroregression Syndrome (UNS), or Childhood-Onset Neurodegeneration with Brain Atrophy (CONDBA). To date, only 17 cases have been reported worldwide. The molecular etiology is a pathogenic variant, E210K, within the HMG-box 2 of Upstream Binding Transcription Factor (UBTF). UBTF, a nucleolar protein, plays an important role in ribosomal RNA (rRNA) synthesis, nucleolar integrity, and cell survival. This variant causes unstable preinitiation complexes to form, resulting in altered rDNA chromatin structures, rRNA dysregulation, DNA damage, and ultimately, neurodegeneration. Defining clinical characteristics of the disorder include but are not limited to developmental regression beginning at approximately three years of age, progressive motor dysfunction, declining cognition, ambulatory loss, and behavioral problems. Histological and neuroimaging abnormalities include cortical atrophy, white matter deficits, and enlarged ventricles. Herein, we present a detailed overview of all published cases as well as the functional roles of UBTF to better understand the pathophysiology. Bringing undiagnosed cases to the attention of clinicians and researchers by making them aware of the clinical features will improve research and support the development of therapeutic interventions.

Schlagwörter

Stichwörter der Autor:innen

DNA damage responseUBTFbehavioral symptomschildhood neurological disordersneurodegenerationneurodevelopment

Autor:innen und Institutionen

  • Department of Neurology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38104, USA.
  • Neuroscience Institute, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
  • Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
  • Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
  • Division of Regenerative and Rehabilitation Sciences, Department of Physical Therapy, Center for Muscle, Metabolism and Neuropathology, College of Health Professions, University of Tennessee Health Science Center, Memph…

ORCID-Profile: Anneliesse A Braden, Mohammad Moshahid Khan

Förderung

  • NINDS NIH HHS
  • National Institute of Health

Zitieren

APA

Braden, A. A., Xiao, J., Hori, R., Brown, C., & Khan, M. M. (2024). An Overview of UBTF Neuroregression Syndrome. Brain Sciences, 14(2), 179. https://doi.org/10.3390/brainsci14020179

Vancouver

Braden AA, Xiao J, Hori R, Brown C, Khan MM. An Overview of UBTF Neuroregression Syndrome. Brain Sciences. 2024;14(2):179. doi:10.3390/brainsci14020179

BibTeX
@article{Braden2024,
  author = {Braden, Anneliesse A and Xiao, Jianfeng and Hori, Roderick and Brown, Chester and Khan, Mohammad Moshahid},
  title = {An Overview of UBTF Neuroregression Syndrome},
  journal = {Brain Sciences},
  year = {2024},
  volume = {14},
  number = {2},
  pages = {179},
  doi = {10.3390/brainsci14020179}
}
Kostenlos starten →